Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Van Lenten

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Nature Reviews. Cardiology|February 10, 2011
HDL and cardiovascular disease: atherogenic and atheroprotective mechanismsMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Journal of Lipid Research|October 29, 2008
The role of dysfunctional HDL in atherosclerosisMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Current Drug Targets|March 14, 2008
Apo A-1 mimetic peptides as atheroprotective agents in murine modelsMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 18, 2009
Structure and function of HDL mimeticsMohamad Navab, Ishaiahu Shechter, G M Anantharamaiah, et al.
Journal of Clinical Lipidology|May 2, 2008
Peptide Mimetics of Apolipoproteins Improve HDL FunctionMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|October 28, 2008
Multiple indications for anti-inflammatory apolipoprotein mimetic peptidesBrian J Van Lenten, Mohamad Navab, G M Anantharamaiah, et al.
Nature Clinical Practice. Endocrinology & Metabolism|September 8, 2006
Mechanisms of disease: proatherogenic HDL--an evolving fieldMohamad Navab, Gattadahalli M Anantharamaiah, Srinivasa T Reddy, et al.
Current Opinion in Lipidology|November 6, 2004
Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversalMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Journal of Lipid Research|August 19, 2007
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbitsBrian J Van Lenten, Alan C Wagner, Mohamad Navab, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 19, 2012
High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literatureMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Nature Reviews. Cardiology|February 10, 2011
HDL and cardiovascular disease: atherogenic and atheroprotective mechanismsMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Journal of Lipid Research|October 29, 2008
The role of dysfunctional HDL in atherosclerosisMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Current Drug Targets|March 14, 2008
Apo A-1 mimetic peptides as atheroprotective agents in murine modelsMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 18, 2009
Structure and function of HDL mimeticsMohamad Navab, Ishaiahu Shechter, G M Anantharamaiah, et al.
Journal of Clinical Lipidology|May 2, 2008
Peptide Mimetics of Apolipoproteins Improve HDL FunctionMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|October 28, 2008
Multiple indications for anti-inflammatory apolipoprotein mimetic peptidesBrian J Van Lenten, Mohamad Navab, G M Anantharamaiah, et al.
Nature Clinical Practice. Endocrinology & Metabolism|September 8, 2006
Mechanisms of disease: proatherogenic HDL--an evolving fieldMohamad Navab, Gattadahalli M Anantharamaiah, Srinivasa T Reddy, et al.
Current Opinion in Lipidology|November 6, 2004
Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversalMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Journal of Lipid Research|August 19, 2007
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbitsBrian J Van Lenten, Alan C Wagner, Mohamad Navab, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 19, 2012
High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literatureMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Pageof 3